亚司匹林的药物基因组学和药物动力学在产前的预防中
Kenean Getaneh Tlaye1, Gashaw Garedew Woldeamanuel1, Kenneth Chi-Yin Wong2
1Faculty of Medicine, Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin. (K.G.T., G.G.W., L.C., R.Z., X.W., L.N.-H., B.W.L., Y.W., L.C.P., C.C.W.).
Circulation research
|May 7, 2025
概括
尽管使用阿司匹林,但孕前也可能发生. 这项研究发现胎盘GLYAT,而不是母性遗传,限制阿司匹林.
科学领域:
- 产科和妇科 产科和妇科
- 药物基因组学 药物基因组学
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 孕前会影响怀孕,一些女性尽管服用低剂量阿司匹林治疗,但仍会患上这种疾病.
- 了解阿司匹林不反应对于高风险怀孕至关重要.
研究的目的:
- 为了研究在产前症中阿司匹林不响应的机制.
- 探索遗传多态化和阿司匹林代谢在治疗失败中的作用.
主要方法:
- 对抗阿司匹林不响应和不响应的女性的基因变异,阿司匹林水解率和胎盘代谢物度进行比较.
- 在胎盘组织中分析了阿司匹林代谢酶 (AME) 的表达.
- 在体外检查了AME对胎盘细胞的影响.
主要成果:
- 没有发现母亲遗传多态性和阿司匹林不响应之间的关联.
- 胎盘甘氨酸-N-转移酶 (GLYAT) 在无反应病例中显著上调.
- 过度表达的GLYAT减少了沙酸在胎盘细胞中的有益作用.
结论:
- 母亲遗传学和血阿司匹林代谢不确定低剂量阿司匹林在预防产前的有效性.
- 胎盘GLYAT上调在阿司匹林不响应中起着关键作用,因为它限制了酸对胎盘的影响.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
388
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
388
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
31
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
31
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
34
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
34
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Factors Influencing Drug Absorption: Presystemic Elimination
153
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
153
Factors Affecting Drug Biotransformation: Biological
71
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
71


